Measured Wealth Private Client Group LLC Purchases New Stake in Cardinal Health, Inc. $CAH

Measured Wealth Private Client Group LLC acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,254 shares of the company’s stock, valued at approximately $211,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Greykasell Wealth Strategies Inc. acquired a new position in shares of Cardinal Health in the 1st quarter valued at about $26,000. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC lifted its position in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares in the last quarter. Vermillion & White Wealth Management Group LLC boosted its stake in shares of Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 71 shares during the period. Finally, NewSquare Capital LLC grew its holdings in shares of Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after acquiring an additional 107 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.4%

Shares of Cardinal Health stock opened at $212.26 on Friday. Cardinal Health, Inc. has a 12-month low of $114.60 and a 12-month high of $214.93. The stock has a 50 day moving average price of $177.57 and a two-hundred day moving average price of $163.29. The stock has a market capitalization of $50.43 billion, a P/E ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of research reports. Argus lifted their price objective on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Evercore ISI raised their price target on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Leerink Partners raised their price objective on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research report on Monday, November 17th. Finally, Citigroup boosted their target price on shares of Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday, October 31st. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $206.57.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.